
Ko Hung Chan
Examiner (ID: 11956, Phone: (571)272-6816 , Office: P/3631 )
| Most Active Art Unit | 3631 |
| Art Unit(s) | 3632, 3505, 2899, 3637, 3631 |
| Total Applications | 2366 |
| Issued Applications | 1619 |
| Pending Applications | 110 |
| Abandoned Applications | 657 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19301973
[patent_doc_number] => 20240230545
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/277834
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277834
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277834 | ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION | Feb 24, 2022 | Pending |
Array
(
[id] => 19142448
[patent_doc_number] => 20240141287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => BACTERIAL STRAINS HAVING PESTICIDAL ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/546967
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546967
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546967 | BACTERIAL STRAINS HAVING PESTICIDAL ACTIVITY AND USE THEREOF | Feb 20, 2022 | Pending |
Array
(
[id] => 17838106
[patent_doc_number] => 20220275411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Expression and Secretion of UV Absorbent Material from Transformed Bacteria
[patent_app_type] => utility
[patent_app_number] => 17/674161
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674161
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674161 | Expression and secretion of UV absorbent material from transformed bacteria | Feb 16, 2022 | Issued |
Array
(
[id] => 18777850
[patent_doc_number] => 11819526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Lactobacillus Gasseri KBL697 strain and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/673488
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 29
[patent_no_of_words] => 12570
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673488 | Lactobacillus Gasseri KBL697 strain and use thereof | Feb 15, 2022 | Issued |
Array
(
[id] => 17804988
[patent_doc_number] => 20220256823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME
[patent_app_type] => utility
[patent_app_number] => 17/673581
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673581 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME | Feb 15, 2022 | Pending |
Array
(
[id] => 17625829
[patent_doc_number] => 20220160844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE
[patent_app_type] => utility
[patent_app_number] => 17/670702
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670702 | LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE | Feb 13, 2022 | Abandoned |
Array
(
[id] => 19656973
[patent_doc_number] => 20240424038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => BLUE-GREEN ALGAE-CONTAINING TABLET
[patent_app_type] => utility
[patent_app_number] => 18/273796
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273796 | BLUE-GREEN ALGAE-CONTAINING TABLET | Feb 9, 2022 | Pending |
Array
(
[id] => 17609901
[patent_doc_number] => 20220152180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => CHIMERIC VACCINE ANTIGENS FOR ANAPLASMOSIS
[patent_app_type] => utility
[patent_app_number] => 17/590290
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590290 | Chimeric vaccine antigens for anaplasmosis | Jan 31, 2022 | Issued |
Array
(
[id] => 18664881
[patent_doc_number] => 11771746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Method to reduce tick population with a universal tick antigen
[patent_app_type] => utility
[patent_app_number] => 17/922173
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5034
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922173 | Method to reduce tick population with a universal tick antigen | Jan 9, 2022 | Issued |
Array
(
[id] => 17760069
[patent_doc_number] => 20220233681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER
[patent_app_type] => utility
[patent_app_number] => 17/566901
[patent_app_country] => US
[patent_app_date] => 2021-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17566901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/566901 | LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER | Dec 30, 2021 | Pending |
Array
(
[id] => 17503515
[patent_doc_number] => 20220096617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => ANTI-MALARIA COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/553098
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553098 | ANTI-MALARIA COMPOSITIONS AND METHODS | Dec 15, 2021 | Abandoned |
Array
(
[id] => 17625846
[patent_doc_number] => 20220160861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => VACCINE COMPOSITION AGAINST CHLAMYDIACEAE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/552256
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552256 | Vaccine composition against Chlamydiaceae infections | Dec 14, 2021 | Issued |
Array
(
[id] => 18953628
[patent_doc_number] => 20240041955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A LACTOBACILLUS CRISPATUS STRAIN AND/OR OF A COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 18/265694
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265694 | COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A LACTOBACILLUS CRISPATUS STRAIN AND/OR OF A COMPOSITION COMPRISING SAME | Dec 13, 2021 | Pending |
Array
(
[id] => 17479764
[patent_doc_number] => 20220087268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/540823
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/540823 | BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY | Dec 1, 2021 | Pending |
Array
(
[id] => 20246709
[patent_doc_number] => 20250295578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => METHODS AND COMPOSITIONS FOR MICROBIAL TREATMENT OF SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/254961
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254961 | METHODS AND COMPOSITIONS FOR MICROBIAL TREATMENT OF SKIN DISORDERS | Nov 30, 2021 | Pending |
Array
(
[id] => 19930362
[patent_doc_number] => 12303555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
[patent_app_type] => utility
[patent_app_number] => 17/525804
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2133
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525804 | Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages | Nov 11, 2021 | Issued |
Array
(
[id] => 19701492
[patent_doc_number] => 12195501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Mutant fragments of OspA and methods and uses relating thereto
[patent_app_type] => utility
[patent_app_number] => 17/517477
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 25283
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517477 | Mutant fragments of OspA and methods and uses relating thereto | Nov 1, 2021 | Issued |
Array
(
[id] => 18915775
[patent_doc_number] => 11878041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Compositions and methods for treating the eye
[patent_app_type] => utility
[patent_app_number] => 17/515882
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12457
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17515882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/515882 | Compositions and methods for treating the eye | Oct 31, 2021 | Issued |
Array
(
[id] => 19677080
[patent_doc_number] => 12188934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Signatures and determinants for diagnosing infections and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/507994
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 108
[patent_no_of_words] => 60845
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507994 | Signatures and determinants for diagnosing infections and methods of use thereof | Oct 21, 2021 | Issued |
Array
(
[id] => 18215202
[patent_doc_number] => 11590115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/494068
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3041
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494068
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494068 | None | Oct 4, 2021 | Issued |